Genelux Corp (GNLX)
2.005
-0.20
(-8.86%)
USD |
NASDAQ |
Jun 28, 16:00
2.11
+0.10
(+5.24%)
After-Hours: 20:00
Genelux Total Liabilities (Quarterly): 9.592M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.592M |
| December 31, 2023 | 8.42M |
| September 30, 2023 | 10.04M |
| June 30, 2023 | 9.107M |
| March 31, 2023 | 11.92M |
| Date | Value |
|---|---|
| December 31, 2022 | 41.31M |
| September 30, 2022 | 38.52M |
| June 30, 2022 | 48.19M |
| March 31, 2022 | 46.74M |
| December 31, 2021 | 41.24M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.42M
Minimum
Dec 2023
48.19M
Maximum
Jun 2022
26.51M
Average
25.22M
Median
Total Liabilities (Quarterly) Benchmarks
| Verastem Inc | 77.32M |
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.581M |
| NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.68M |
| Shareholders Equity (Quarterly) | 15.08M |
| Current Ratio | 2.717 |
| Net Debt Paydown Yield | 2.87% |